Study to Identify the Reduction of Exacerbations Resulting in Hospital Admission in Patients With COPD.

Identification of the Reduction of Exacerbations Resulting in Hospital Admission in COPD Patients After the Use of the Breath Detect Telemedicine Platform.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05440188

Acronym

BDS

Enrollment

Registered

2022-06-30

Start date

2022-10-01

Completion date

2023-10-23

Last updated

2023-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD Exacerbation

Keywords

telemedicine

Brief summary

identification of the reduction of exacerbations resulting in hospital admission in COPD patients after the use of the Breath Detect telemedicine platform.

Interventions

DIAGNOSTIC_TESTBreath Detect Platform

Use of the Breath Detect platform for respiratory health monitoring.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

65 Years to No maximum

Healthy volunteers

Inclusion criteria

* COPD diagnosed in GOLD II state or higher

Exclusion criteria

* Can´t read and talk in spanish

Design outcomes

Primary

Measure	Time frame
Number of hospital admissions due to exacerbations	24 weeks

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026